ClinicalTrials.gov
ClinicalTrials.gov Menu

Sorafenib in Newly Diagnosed High Grade Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00884416
Recruitment Status : Completed
First Posted : April 20, 2009
Last Update Posted : November 4, 2014
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Andreas F. Hottinger, University Hospital, Geneva